Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2301 | 2220 | 54.2 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | E2F | Author keyword | 150 | 43% | 12% | 266 |
2 | P107 | Author keyword | 69 | 63% | 3% | 70 |
3 | P130 | Author keyword | 47 | 56% | 3% | 57 |
4 | E2F1 | Author keyword | 42 | 31% | 5% | 115 |
5 | E2F 1 | Author keyword | 36 | 41% | 3% | 69 |
6 | E2F4 | Author keyword | 25 | 65% | 1% | 24 |
7 | RB2 P130 | Author keyword | 23 | 74% | 1% | 17 |
8 | RB | Author keyword | 23 | 17% | 6% | 125 |
9 | PRB | Author keyword | 19 | 18% | 4% | 97 |
10 | PRB2 P130 | Author keyword | 15 | 62% | 1% | 16 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | E2F | 150 | 43% | 12% | 266 | Search E2F | Search E2F |
2 | P107 | 69 | 63% | 3% | 70 | Search P107 | Search P107 |
3 | P130 | 47 | 56% | 3% | 57 | Search P130 | Search P130 |
4 | E2F1 | 42 | 31% | 5% | 115 | Search E2F1 | Search E2F1 |
5 | E2F 1 | 36 | 41% | 3% | 69 | Search E2F+1 | Search E2F+1 |
6 | E2F4 | 25 | 65% | 1% | 24 | Search E2F4 | Search E2F4 |
7 | RB2 P130 | 23 | 74% | 1% | 17 | Search RB2+P130 | Search RB2+P130 |
8 | RB | 23 | 17% | 6% | 125 | Search RB | Search RB |
9 | PRB | 19 | 18% | 4% | 97 | Search PRB | Search PRB |
10 | PRB2 P130 | 15 | 62% | 1% | 16 | Search PRB2+P130 | Search PRB2+P130 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | S PHASE ENTRY | 199 | 51% | 13% | 280 |
2 | P107 | 148 | 64% | 6% | 144 |
3 | TRANSCRIPTION FACTOR E2F | 126 | 54% | 7% | 163 |
4 | TRANSCRIPTION FACTOR E2F 1 | 122 | 70% | 5% | 101 |
5 | PRB | 99 | 52% | 6% | 137 |
6 | FIBROBLASTS LEADS | 65 | 90% | 1% | 28 |
7 | RETINOBLASTOMA PROTEIN | 63 | 12% | 23% | 501 |
8 | RETINOBLASTOMA GENE PRODUCT | 56 | 20% | 11% | 247 |
9 | E2F | 52 | 29% | 7% | 154 |
10 | E2F1 INDUCED APOPTOSIS | 50 | 84% | 1% | 27 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Molecular mechanisms underlying RB protein function | 2013 | 67 | 89 | 75% |
The regulation of E2F by pRB-family proteins | 1998 | 1610 | 183 | 87% |
The E2F transcriptional network: old acquaintances with new faces | 2005 | 357 | 213 | 75% |
Emerging roles of E2Fs in cancer: an exit from cell cycle control | 2009 | 262 | 199 | 61% |
Sibling rivalry in the E2F family | 2002 | 677 | 128 | 80% |
Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis | 2006 | 234 | 192 | 77% |
RB and cell cycle progression | 2006 | 282 | 70 | 61% |
Cellular mechanisms of tumour suppression by the retinoblastoma gene | 2008 | 280 | 203 | 49% |
Pocket proteins and cell cycle control | 2005 | 341 | 172 | 56% |
The Rb/E2F pathway: expanding roles and emerging paradigms | 2000 | 728 | 163 | 58% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENET CANC GRP | 6 | 80% | 0.2% | 4 |
2 | VECTOROL EXPT GENE THER Y | 6 | 35% | 0.7% | 15 |
3 | IST RIC CARDIOPNEUMOL AO MONALDI | 6 | 100% | 0.2% | 4 |
4 | SBARRO CANC MOL MED | 5 | 10% | 2.3% | 50 |
5 | SCI ODONTOSTOMATOL MAXILLO CIALI | 3 | 57% | 0.2% | 4 |
6 | CANC BIOL PROGRAMMEEPITHELIAL PATHOBIOL GRP | 3 | 100% | 0.1% | 3 |
7 | CELL CYCLE HUMAN DIS GRP | 3 | 60% | 0.1% | 3 |
8 | DIPARTIMENTO SCI ODONTOSTOMATOL MAXILLO CIAL | 2 | 44% | 0.2% | 4 |
9 | DIPARTIMENTO SCI ODONTOSTOMATOL MAXILLO CIALI | 2 | 32% | 0.3% | 6 |
10 | PHYSIOL PHARMACOL REGULATORY BIOL | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000192815 | RB1 GENE//RETINOBLASTOMA//RB 1 |
2 | 0.0000128852 | DREF//INSECT BIOMED//DNA REPLICATION RELATED GENE |
3 | 0.0000105812 | CYCLIN D1//CYCLIN E//CCND1 |
4 | 0.0000090351 | ARID3B//JUMONJI//AT RICH INTERACTION DOMAIN |
5 | 0.0000075176 | PEDIAT CHILDREN SURG//SOMATIC GENOME VARIATIONS//HUMAN PERIPHERAL CELLS |
6 | 0.0000070538 | P14ARF//P16//P16INK4A |
7 | 0.0000068880 | GANKYRIN//P28GANK//PSMD10 |
8 | 0.0000065496 | E1A//ADENOVIRUS E1A GENE//E4ORF6 |
9 | 0.0000061394 | FLAVOPIRIDOL//CELL CYCLE REGULAT GRP//ROSCOVITINE |
10 | 0.0000060487 | SKP2//P27KIP1//P27 |